outcomes following first-line therapy in routine clinical practice in alcl
Published 4 years ago • 124 plays • Length 6:28Download video MP4
Download video MP3
Similar videos
-
1:25
genomic testing and therapeutic decisions in routine clinical practice in cll
-
1:10
the importance of incorporating patient-reported outcomes in clinical practice
-
1:44
the impact of acalabrutinib treatment by line of therapy in patients with cll
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
0:45
difference between quality of life & patient-reported outcomes
-
1:35
55-month follow-up from glow: fixed-duration ibr ven vs clb o in treatment naïve cll
-
2:54
welcome to the video journal of oncology 🎥 🗞️ 🔬
-
2:30
towards strategies to optimize outcomes in cll
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
2:06
effects of dose adjustment of first-line ibrutinib on real-world dosing patterns and outcomes in cll
-
3:44
aml: novel conditioning and maintenance strategies
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
3:19
first-line treatment selection in myelofibrosis